MX2009010561A - Sistema de liberacion transdermal de droga para principios activos liquidos. - Google Patents

Sistema de liberacion transdermal de droga para principios activos liquidos.

Info

Publication number
MX2009010561A
MX2009010561A MX2009010561A MX2009010561A MX2009010561A MX 2009010561 A MX2009010561 A MX 2009010561A MX 2009010561 A MX2009010561 A MX 2009010561A MX 2009010561 A MX2009010561 A MX 2009010561A MX 2009010561 A MX2009010561 A MX 2009010561A
Authority
MX
Mexico
Prior art keywords
drug
active ingredient
layer
adhesive
delivery system
Prior art date
Application number
MX2009010561A
Other languages
English (en)
Inventor
Paula Forlano
Alejandro Scasso
Francisco Stefano
Original Assignee
Amarin Technologies S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amarin Technologies S A filed Critical Amarin Technologies S A
Publication of MX2009010561A publication Critical patent/MX2009010561A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Un dispositivo monol?tico para la administraci?n transdermal de un ingrediente farmac?uticamente activo el cual es seleccionado entre propargilaminas y rivastigmina y es l?quido a 25?C, tiene una capa de matriz adhesiva que incluye al ingrediente activo en un pol?mero acr?lico adhesivo sensible a la presi?n sin ning?n agente reticulante que contenga ?tomos met?licos, teniendo el adhesivo un valor de cohesividad de entre 1.5 y 15 horas, e incluyendo adem?s un coadyuvante no vol?til seleccionado entre escualeno y trietilcitrato presente en la capa en una cantidad de 1 a 15% en peso. La combinaci?n provee una adecuada liberaci?n de la droga estando en uso, reduce la p?rdida de la droga durante el paso de secado en la manufactura, reduce la interacci?n qu?mica de la capa con la droga y resulta en un bajo nivel de irritaci?n de la piel.
MX2009010561A 2008-10-02 2009-09-30 Sistema de liberacion transdermal de droga para principios activos liquidos. MX2009010561A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08253215 2008-10-02

Publications (1)

Publication Number Publication Date
MX2009010561A true MX2009010561A (es) 2010-05-17

Family

ID=40344848

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009010561A MX2009010561A (es) 2008-10-02 2009-09-30 Sistema de liberacion transdermal de droga para principios activos liquidos.

Country Status (9)

Country Link
US (1) US20100087768A1 (es)
EP (1) EP2172194B1 (es)
AR (1) AR073704A1 (es)
AT (1) ATE485035T1 (es)
BR (1) BRPI0904016A2 (es)
CA (1) CA2678320C (es)
DE (1) DE602009000290D1 (es)
ES (1) ES2354596T3 (es)
MX (1) MX2009010561A (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2467749C1 (ru) * 2011-04-21 2012-11-27 Государственное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко" Министерства здравоохранения и социального развития Российской Федерации Способ коррекции уровня сахара крови и лечения пациентов с сахарным диабетом второго типа с когнитивными нарушениями

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10076502B2 (en) * 2009-12-22 2018-09-18 Luye Pharma Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
JP5619438B2 (ja) * 2010-03-12 2014-11-05 株式会社フジモト・コーポレーション セレギリン含有貼付製剤
EA023786B1 (ru) * 2010-04-30 2016-07-29 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Трансдермальные композиции на основе пропиниламиноиндана
DE102010026903A1 (de) 2010-07-12 2012-01-12 Amw Gmbh Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff
ES2720952T3 (es) 2010-07-21 2019-07-25 3M Innovative Properties Co Composiciones adhesivas transdérmicas, dispositivos y métodos
EP2688561B1 (en) 2011-03-24 2018-08-22 Teikoku Pharma USA, Inc. Transdermal compositions comprising an active agent layer and an active agent conversion layer
US9585862B2 (en) 2011-05-20 2017-03-07 Sk Chemicals Co., Ltd. Patch containing rivastigmine
AR082640A1 (es) * 2011-08-25 2012-12-19 Amarin Technologies S A Un dispositivo para la administracion transdermal de compuestos alcalinos susceptibles a la degradacion en su forma no salificada
DE102011111865A1 (de) * 2011-08-31 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für 5-Aminolävulinsäurehydrochlorid
WO2013031992A1 (ja) 2011-08-31 2013-03-07 積水メディカル株式会社 貼付剤
US9913812B2 (en) 2011-11-09 2018-03-13 Teikoku Pharma Usa, Inc. Methods for the treatment of skin neoplasms
EP2594261A1 (en) 2011-11-18 2013-05-22 Labtec GmbH Composition for transdermal administration of rivastigmine
DE102012000369A1 (de) 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
US20130202675A1 (en) 2012-02-03 2013-08-08 Dynasil Biomedical Corporation Systems and methods for the fabrication of tissue patches
US8871245B2 (en) * 2012-02-28 2014-10-28 Nichiban Co., Ltd. Transdermal patch
WO2013150542A2 (en) * 2012-04-05 2013-10-10 Sparsha Pharma International Private Limited A transdermal patch for treatment of dementia or alzheimer type dementia
US9539201B2 (en) 2012-04-20 2017-01-10 KAT Transdermals LLC Selegiline transdermal system
JP6153135B2 (ja) * 2012-06-12 2017-06-28 株式会社 ケイ・エム トランスダーム 貼付剤
JP6050896B2 (ja) 2012-11-02 2016-12-21 テイコク ファーマ ユーエスエー インコーポレーテッド プロピニルアミノインダン経皮組成物
WO2014111790A2 (en) 2013-01-15 2014-07-24 Zydus Technologies Limited Stable transdermal pharmaceutical drug delivery system comprising rivastigmine
AR095259A1 (es) * 2013-03-15 2015-09-30 Noven Pharma Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria
WO2015174502A1 (ja) 2014-05-15 2015-11-19 ニチバン株式会社 リバスチグミンを含有する貼付剤のための包装体
US9833538B2 (en) 2015-08-07 2017-12-05 Xcede Technologies, Inc. Adhesive compositions and related methods
EP3331577A4 (en) 2015-08-07 2019-07-17 Xcede Technologies, Inc. ADHESIVE COMPOSITIONS AND ASSOCIATED METHODS
JP7029244B2 (ja) * 2017-08-01 2022-03-03 久光製薬株式会社 貼付剤
TWI720366B (zh) * 2018-11-16 2021-03-01 得生製藥股份有限公司 經皮吸收貼片
CN115400090A (zh) * 2022-10-09 2022-11-29 北京新领先医药科技发展有限公司 一种雷沙吉兰的口崩片组合物及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US593807A (en) * 1897-11-16 Magic toy
HU201906B (en) * 1987-03-04 1991-01-28 Sandoz Ag Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them
EP0593807A1 (en) 1992-10-22 1994-04-27 LTS Lohmann Therapie-Systeme GmbH & Co. KG Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
US5462746A (en) * 1992-11-02 1995-10-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
DE4237453C1 (es) * 1992-11-06 1993-08-19 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
US6316022B1 (en) * 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
US5891957A (en) * 1996-10-24 1999-04-06 Shell Oil Company Adhesive composition for skin adhesion and bandage applications
US7150881B2 (en) * 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
GB9800526D0 (en) * 1998-01-12 1998-03-11 Ciba Geigy Ag Organic compounds
AU3470600A (en) * 1999-01-14 2000-08-01 David Houze Compositions and methods for drug delivery
AU2001292781A1 (en) * 2000-09-19 2002-04-02 National Starch And Chemical Investment Holding Corporation Acryl adhesive useful in transdermal drug delivery systems
DE10141652B4 (de) * 2001-08-24 2011-04-07 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
AR033748A1 (es) * 2002-05-15 2004-01-07 Thalas Group Inc Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
WO2005046600A2 (en) * 2003-11-07 2005-05-26 Nexmed Holdings, Inc. Transdermal tulobuterol delivery

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2467749C1 (ru) * 2011-04-21 2012-11-27 Государственное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко" Министерства здравоохранения и социального развития Российской Федерации Способ коррекции уровня сахара крови и лечения пациентов с сахарным диабетом второго типа с когнитивными нарушениями

Also Published As

Publication number Publication date
ATE485035T1 (de) 2010-11-15
DE602009000290D1 (de) 2010-12-02
CA2678320C (en) 2016-04-12
EP2172194B1 (en) 2010-10-20
CA2678320A1 (en) 2010-04-02
ES2354596T3 (es) 2011-03-16
AR073704A1 (es) 2010-11-24
US20100087768A1 (en) 2010-04-08
EP2172194A1 (en) 2010-04-07
BRPI0904016A2 (pt) 2011-06-07

Similar Documents

Publication Publication Date Title
MX2009010561A (es) Sistema de liberacion transdermal de droga para principios activos liquidos.
US10987316B2 (en) Compositions and methods for transdermal delivery of tertiary amine drugs
KR101000945B1 (ko) 매트릭스형 경피투여제 및 이의 제조방법
TW200514590A (en) Hydrophilic adhesives for delivery of herbal medicines
CN102085198A (zh) 透皮给药系统
KR20160096155A (ko) 커버재가 부착된 첩부제 및 커버재가 부착된 첩부제 키트
HUE031662T2 (en) Transdermal drug delivery system
JP2006288887A (ja) 貼付製剤
WO2011029948A3 (de) Transdermales therapeutisches system zur verabreichung von fentanyl oder einem analogstoff davon
JP2010510260A5 (es)
KR100940245B1 (ko) 경피 약물 전달 시스템에 유용한 비반응성 접착제
JP4430120B2 (ja) 抗真菌症用貼付剤
TWI415636B (zh) Bisoprolol transdermal device
Czech et al. Acrylic pressure‐sensitive adhesive for transdermal drug delivery systems
AU2016244227A1 (en) Once-a-day replacement transdermal administration of fentanyl
JP2007063260A (ja) ニコチン経皮吸収製剤の製造方法
KR20080049843A (ko) 아크릴 폴리머계 접착제
Kim et al. Effect of plasticizers on drug-in-adhesive patches containing 5-fluorouracil
AU2004210406B2 (en) Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances, and the use thereof
TW200800190A (en) Nicotine transdermal preparation and production method thereof
US20090274747A1 (en) Pressure-Sensitive Adhesive Base and Medical Adhesive Patch Including the Pressure-Sensitive Adhesive Base
ZA200505629B (en) Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances and the use thereof
CN102970974B (zh) 用于治疗皮炎和牛皮癣的去炎松缩酮制剂
Miller Transdermal product formulation development
WO2008095597A3 (de) Transdermales therapeutisches system zur verabreichung wasserlöslicher wirkstoffe

Legal Events

Date Code Title Description
FG Grant or registration